Iwata Godo has a proven track record of advising pharma companies, medical device manufacturers, wholesalers of pharmaceuticals and medical devices, and food and beverage manufacturers, both Japanese and foreign, on a wide range of regulation, including the Act on Securing Quality, Efficacy and Safety of Products, the Clinical Trials Act, competition rules of self-regulatory associations, the Food Labeling Act, the Health Promotion Act and the Medical Care Act.
In addition to this sector-specific regulatory advice, we also respond to the wide range of needs of pharma and healthcare companies, with comprehensive legal support in intellectual property, competition law, data privacy, employment law and other areas.
Publications Related to Pharma and Healthcare
-
2023.07
Tago Shinya, Ikeda Minako and Landry Guesdon co-author "Pharmaceutical Advertising 2023: Japan" in Global Legal Group's International Comparative Legal Guide
-
2023.02
Fujiwara Hiroki and Okanami Kentaro co-author "Medical Industry (3)" for the series "Labor Management Counseling for Working Styles in Different Industries and Occupations" in the March issue of Jinji Romu Jitsumu no Q&A
- Author：
- FUJIWARA Hiroki OKANAMI Kentaro
-
2022.12
Tago Shinya, Landry Guesdon and Ikeda Minako co-author the Japan chapter of "The Legal 500: Pharmaceutical Advertising Country Comparative Guide"
- Author：
- TAGO Shinya Landry GUESDON IKEDA Minako